Food PK differences can be represented as a PK modeling construct describing how dissolution timing, gastric emptying, and intestinal transit modify early concentration formation. Food-modified PK parameter sets may include slower dissolution, delayed gastric emptying, altered intestinal transit, or flatter absorption slopes. These differences do not imply clinical outcomes; they are mechanistic constructs used to compare modeled trajectories. Sildenafil PK geometry is sensitive to food-modified input timing because dissolution and early absorption are represented as sequential processes connecting the administered dose with systemic input. If dissolution is delayed, the modeled input function begins later or becomes more distributed across time. If gastric emptying is delayed, dissolved material reaches the intestinal absorption region according to a shifted transit function. Changes in intestinal transit can further alter the temporal distribution of available drug. Food PK differences therefore modify rising-phase geometry, peak timing, and early disposition while the underlying compound remains unchanged. Link to food impact.
PK determinants shape food-modified concentration–time geometry by controlling when input begins, how quickly it develops, and how the resulting exposure is subsequently redistributed and removed. Dissolution timing determines when sildenafil becomes available for modeled absorption, while gastric emptying determines when dissolved material reaches the principal absorption region. Intestinal transit determines the temporal distribution of drug across regions with potentially different absorption contributions. Absorption geometry then converts these processes into a rising concentration curve whose slope and curvature depend on the selected input parameters. Distribution kinetics and metabolic turnover act concurrently, determining how food-modified input is translated into central and peripheral exposure while removal proceeds. Different parameter sets can therefore flatten or steepen the rising-phase geometry, shifting modeled Tmax and modifying peak height. Tmax and Cmax describe peak geometry, but they do not independently define onset. Food-modified transit and absorption parameters can be examined separately from later disposition parameters. Link to gastric emptying and tmax comparison.
PD mapping interprets food-modified PK trajectories by specifying how a concentration-time curve is translated into a modeled effect coordinate once concentration approaches a defined threshold region. PD variability can shift threshold placement, allowing identical PK trajectories to produce different onset coordinates without changing dissolution, transit, absorption, distribution, or metabolic parameters. Conversely, changing food-related PK parameters can move the trajectory while leaving the PD threshold fixed. This separates the input and disposition layers from the concentration-effect layer. A delayed rising trajectory can intersect the same threshold at a later modeled coordinate, while a flatter trajectory can alter the timing and shape of threshold-region entry. The descending trajectory can be evaluated separately, allowing onset and duration to occupy different regions of the same PK→PD geometry. Food PK differences are therefore interpreted through dissolution, gastric emptying, intestinal transit, absorption, distribution, and removal parameters rather than clinical comparisons. The resulting model describes parameter-dependent timing relationships. Link to pd variability and duration vs onset balance.
Dissolution timing and gastric emptying determine the temporal structure of early sildenafil input in a food-modified PK model. Dissolution can be represented as a process that converts the administered formulation into material available for subsequent absorption. A change in dissolution timing shifts the onset or spread of available input. Gastric emptying then determines when that material reaches the intestinal region represented by the absorption compartment. If the emptying function is delayed or broadened, systemic input can begin later or become distributed over a wider interval. These processes are sequential, so their effects can compound: delayed dissolution followed by delayed emptying produces a later input function than either parameter change alone. The resulting concentration curve is determined by the convolution of formulation release, gastric transit, intestinal availability, and systemic disposition. Food therefore functions in the model as a parameter-set modifier of input timing rather than as an outcome category. Gastric emptying provides the transit parameter connecting upper gastrointestinal timing with systemic input geometry. Link to gastric emptying.
Intestinal transit interacts with absorption geometry by determining how dissolved sildenafil is distributed across the modeled absorption region over time. A transit parameter can be represented as a movement function that controls how quickly available material progresses through successive intestinal segments. Absorption geometry then determines the fraction and rate of systemic input associated with each segment. Faster modeled transit can compress input into a narrower interval, while slower or more dispersed transit can broaden the input function, depending on the specified absorption coefficients. The resulting concentration-time trajectory reflects both where the drug is located and how efficiently each modeled region contributes systemic input. This distinction separates transit from absorption rate: transit describes movement through the gastrointestinal model, whereas absorption rate describes transfer from the available compartment into systemic circulation. Changes in either parameter can alter the slope, curvature, and timing of the rising concentration phase. Food-related PK variability can therefore be decomposed into sequential timing and absorption parameters rather than represented by a single undifferentiated delay. Link to absorption rate.
| PK Domain | Mechanistic Determinant | Link |
|---|---|---|
| Dissolution & Emptying | Input timing. | gastric emptying |
| Absorption | Rising-phase geometry. | absorption curves |
| Transit | Regional absorption timing. | meal timing |
Distribution kinetics determine how food-modified systemic input propagates through the compartments of a PK model. Once sildenafil enters the central compartment, distribution parameters control transfer into and out of peripheral compartments, producing additional curvature between the initial input phase and later concentration decline. A food-modified input function can therefore generate a different concentration trajectory even when distribution parameters remain unchanged, while an altered distribution parameter can further reshape the same input. The distinction is important because absorption determines how drug enters the system, whereas distribution determines how that drug is spatially represented after entry. A delayed or broadened input may interact with rapid distribution differently from the same input paired with slower intercompartmental transfer. The resulting model can show changes in early central concentration, compartmental equilibration, peak timing, and the relationship between central and peripheral exposure. These effects remain mathematical consequences of the specified parameter set. Food-related PK differences can consequently be decomposed into input geometry and disposition geometry rather than treated as a single timing variable. Link to distribution.
Metabolic turnover interacts with food-modified PK geometry by removing sildenafil from the modeled system while absorption and distribution continue. The concentration-time trajectory is therefore generated by the balance between time-dependent input and simultaneous removal. If food-related parameters delay or broaden systemic input, the same metabolic turnover rate is applied across a differently shaped input function. Conversely, changing the turnover parameter modifies the trajectory generated by an otherwise identical food-related input profile. A higher modeled removal rate increases the fraction of input removed during each interval, while a lower rate permits more of the incoming concentration to persist before subsequent elimination. This interaction can modify peak height, rising-phase curvature, and the transition from absorption-dominated to elimination-dominated behavior. Metabolic turnover is therefore a disposition parameter that operates alongside dissolution, gastric emptying, intestinal transit, and absorption rather than replacing them. The complete food-modified trajectory emerges from their combined parameter values. Bioavailability can provide an additional input-efficiency parameter when the model includes systemic availability changes. Link to metabolism.
| PK Domain | Mechanistic Determinant | Link |
|---|---|---|
| Distribution | Compartmental timing. | distribution |
| Metabolic Turnover | Removal competition. | metabolism |
| Bioavailability | Input efficiency. | bioavailability |
Food-modified onset geometry begins with the PK trajectory generated by dissolution, gastric emptying, intestinal transit, absorption, distribution, and removal. These processes determine how concentration moves through time before reaching any specified PD boundary. A delayed input function shifts the rising trajectory along the time axis, while a broader absorption function changes its slope and curvature. Distribution kinetics can add further temporal separation between central and peripheral exposure, and metabolic turnover can reduce concentration while absorption remains active. The resulting curve can therefore have different rising-phase steepness, peak timing, peak magnitude, and decline geometry under different food-related parameter sets. Speed profiles provide a compact representation of these temporal differences by describing how quickly the trajectory moves through successive concentration regions. In this framework, onset is not assigned directly by a food category. Instead, it emerges when the food-modified PK trajectory intersects a predefined PD threshold. Food-related parameters therefore alter the trajectory that enters the PD mapping layer, while the threshold itself remains an independent model component. Link to speed profiles.
PD mapping determines threshold placement under food-modified PK by defining which concentration or effect coordinate represents the onset boundary. When the PD threshold remains fixed, changes in dissolution timing, gastric emptying, intestinal transit, absorption geometry, distribution kinetics, or metabolic turnover move the PK trajectory relative to that boundary. The resulting threshold crossing can therefore occur at a different modeled time even though the PD mapping is unchanged. Alternatively, if PD threshold placement varies while the food-modified PK trajectory remains identical, the threshold crossing also changes. This demonstrates that onset timing is jointly determined by trajectory geometry and concentration-effect mapping. The ascending crossing represents the modeled onset coordinate, while a separate descending crossing can describe a persistence boundary. Tmax and Cmax remain peak descriptors rather than threshold definitions. Onset difference is consequently a temporal comparison between corresponding threshold crossings generated by different parameter sets. The model can isolate PK and PD contributions by changing one layer while holding the other constant. Link to onset difference.
Sildenafil and tadalafil can be represented by distinct food-PK-modified PK→PD parameter sets because their absorption, distribution, metabolic, and elimination parameters are compound-specific. The same food-related perturbation can therefore produce different modeled concentration-time trajectories when applied to each compound. For example, a change in input timing interacts with each compound's absorption geometry, while metabolic turnover and distribution kinetics determine how that input is translated into subsequent exposure. The PD layer then maps each concentration trajectory against its specified threshold relationship. A mechanistic comparison consequently requires the same food parameterization framework, explicit compound-specific PK parameters, and clearly defined PD mappings. Differences can appear in rising-phase curvature, peak coordinates, decline geometry, and threshold-crossing times without converting those differences into claims about real-world outcomes. The comparison is instead a parameter-space analysis of how food-related input perturbations propagate through each compound's PK→PD system. Food impact is therefore represented as an interaction between food-modified input parameters and compound-specific disposition and PD parameters. Link to food impact.
| Balance Domain | Mechanistic Determinant | Link |
|---|---|---|
| PK Trajectory | Exposure development. | speed profiles |
| PD Mapping | Threshold placement. | onset difference |
| PK→PD Balance | Combined geometry. | food impact |
Sildenafil food PK differences can be represented by changes in parameters controlling dissolution timing, gastric emptying, intestinal transit, absorption geometry, distribution kinetics, and metabolic turnover. Dissolution determines when drug becomes available for subsequent input. Gastric emptying determines when that material reaches the modeled intestinal absorption region. Intestinal transit controls the temporal distribution of available material across regions contributing to systemic input. Absorption parameters then determine the rate and shape of systemic entry. Distribution parameters control movement between modeled compartments after entry, while metabolic turnover removes drug from the system. Different combinations of these parameters generate different concentration-time trajectories. The model can therefore represent food as a set of input and disposition parameters rather than as a single categorical variable. Peak timing, peak magnitude, rising-phase curvature, and decline geometry emerge from the combined parameter set.
PK parameters shape food-modified geometry by determining when systemic input begins, how rapidly it develops, how exposure is distributed, and how quickly drug is removed. Dissolution timing controls the initial availability of sildenafil for absorption. Gastric emptying controls the transfer of available material toward the intestinal absorption region. Intestinal transit determines how that material is distributed across time and location within the absorption model. Absorption-rate parameters convert this availability into systemic input and therefore determine the rising-phase slope and curvature. Distribution kinetics subsequently determine movement between central and peripheral compartments. Metabolic turnover and elimination parameters control removal while input and distribution continue. The resulting concentration-time curve is the combined output of these processes. Food-modified PK geometry can therefore be decomposed into input, distribution, and removal components, allowing each parameter class to be varied independently or together in a mechanistic model.
PD parameters interpret food-modified PK trajectories by defining how concentration is mapped onto an effect coordinate and where a specified threshold is placed. A food-modified PK curve can shift because dissolution, gastric emptying, transit, absorption, distribution, or metabolic turnover parameters have changed. If the PD threshold remains fixed, the altered curve reaches that boundary at a different modeled time. If the PK curve remains fixed but the PD threshold changes, the crossing time also changes. This separates PK trajectory formation from PD interpretation. The same concentration-time profile can therefore produce different onset coordinates under different PD mappings, while different food-modified PK profiles can produce different coordinates under one fixed mapping. The resulting model treats onset as a threshold-crossing property of the coupled PK→PD system. No clinical interpretation is required because the analysis concerns only mathematical relationships among concentration, time, and the selected PD boundary.
Sildenafil and tadalafil can be modeled with different food-PK-modified geometries because their underlying PK parameter sets are distinct. A food-related change in dissolution or gastric emptying interacts with each compound's absorption function, while distribution and metabolic parameters determine how the resulting input develops into a complete concentration-time trajectory. The same food parameter change can therefore produce different curve shapes when applied to different compound-specific parameters. The PD layer adds another distinction by defining the concentration-effect relationship and threshold placement used for each model. A mechanistic comparison can examine rising-phase slope, peak timing, peak magnitude, compartmental distribution, and decline behavior while keeping the food-related perturbation explicitly defined. Differences in these modeled coordinates represent parameter-set behavior. They do not themselves establish a clinical outcome. The comparison is therefore a PK→PD geometry exercise in which food modifies input or disposition parameters and each compound translates those changes through its own specified model.
Food PK relates to onset variability through changes in the concentration-time trajectory that precedes a modeled threshold crossing. Variability in dissolution timing can shift when systemic input begins. Gastric emptying and intestinal transit can alter the temporal distribution of available drug, while absorption parameters can change the slope and curvature of the rising phase. Distribution kinetics can modify the relationship between central and peripheral exposure, and metabolic turnover can change the amount removed while absorption continues. Each parameter set can therefore produce a distinct trajectory. If the PD threshold is fixed, these trajectories cross it at different modeled times, creating onset variability within the model. PD variability can add another source of timing variation by changing threshold placement while keeping PK parameters constant. Food-related onset variability is thus the combined result of PK parameter variation and PD mapping. It is a mathematical property of the specified PK→PD parameter space.